Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma

被引:0
作者
Hans C. Lee
Noopur S. Raje
Ola Landgren
Vijay V. Upreti
Jin Wang
Ariel A. Avilion
Xuguang Hu
Erik Rasmussen
Gataree Ngarmchamnanrith
Hisaki Fujii
Andrew Spencer
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Lymphoma/Myeloma
[2] Harvard Medical School,Center for Multiple Myeloma, Massachusetts General Hospital
[3] Memorial Sloan Kettering Cancer Center,Myeloma Service, Department of Medicine
[4] Amgen Inc.,Clinical Pharmacology Modeling & Simulation
[5] Amgen Inc.,Bioanalytical Sciences
[6] Amgen Inc.,Clinical Biomarkers & Diagnostics
[7] Amgen Inc.,Global Biostatistical Science
[8] Amgen Inc.,Clinical Development
[9] Amgen Inc.,Translational Medicine
[10] Monash University,Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital
来源
Leukemia | 2021年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:255 / 258
页数:3
相关论文
共 57 条
  • [21] Arendt BK(undefined)undefined undefined undefined undefined-undefined
  • [22] Harder B(undefined)undefined undefined undefined undefined-undefined
  • [23] Henderson K(undefined)undefined undefined undefined undefined-undefined
  • [24] Kindsvogel W(undefined)undefined undefined undefined undefined-undefined
  • [25] Darce JR(undefined)undefined undefined undefined undefined-undefined
  • [26] Arendt BK(undefined)undefined undefined undefined undefined-undefined
  • [27] Wu X(undefined)undefined undefined undefined undefined-undefined
  • [28] Jelinek DF(undefined)undefined undefined undefined undefined-undefined
  • [29] Rajkumar SV(undefined)undefined undefined undefined undefined-undefined
  • [30] Harousseau JL(undefined)undefined undefined undefined undefined-undefined